134 related articles for article (PubMed ID: 26550128)
1. Anti-tumor effect of RGD modified PTX loaded liposome on prostatic cancer.
Cao Y; Zhou Y; Zhuang Q; Cui L; Xu X; Xu R; He X
Int J Clin Exp Med; 2015; 8(8):12182-91. PubMed ID: 26550128
[TBL] [Abstract][Full Text] [Related]
2. Development of synthetic of peptide-functionalized liposome for enhanced targeted ovarian carcinoma therapy.
Wu H; Yao L; Mei J; Li F
Int J Clin Exp Med; 2014; 7(12):4809-18. PubMed ID: 25663977
[TBL] [Abstract][Full Text] [Related]
3. Development of synthetic of peptide-functionalized liposome for enhanced targeted ovarian carcinoma therapy.
Wu H; Yao L; Mei J; Li F
Int J Clin Exp Pathol; 2015; 8(1):207-16. PubMed ID: 25755707
[TBL] [Abstract][Full Text] [Related]
4. [Preparation and evaluation of RGD and TAT co-modified paclitaxel loaded liposome].
Gao B; Mu W
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 Aug; 39(8):769-74. PubMed ID: 25202944
[TBL] [Abstract][Full Text] [Related]
5. Effect of integrin receptor-targeted liposomal paclitaxel for hepatocellular carcinoma targeting and therapy.
Chen L; Liu Y; Wang W; Liu K
Oncol Lett; 2015 Jul; 10(1):77-84. PubMed ID: 26170980
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of dual-functional liposomes containing paclitaxel for treatment of lung cancer.
Wang RH; Cao HM; Tian ZJ; Jin B; Wang Q; Ma H; Wu J
Oncol Rep; 2015 Feb; 33(2):783-91. PubMed ID: 25482610
[TBL] [Abstract][Full Text] [Related]
7. Delivery of RGD-modified liposome as a targeted colorectal carcinoma therapy and its autophagy mechanism.
Ren Y; Yuan B; Hou S; Sui Y; Yang T; Lv M; Zhou Y; Yu H; Li S; Peng H; Chang N; Liu Y
J Drug Target; 2021 Sep; 29(8):863-874. PubMed ID: 33507113
[TBL] [Abstract][Full Text] [Related]
8. RGD-based strategies for improving antitumor activity of paclitaxel-loaded liposomes in nude mice xenografted with human ovarian cancer.
Zhao H; Wang JC; Sun QS; Luo CL; Zhang Q
J Drug Target; 2009 Jan; 17(1):10-8. PubMed ID: 19016068
[TBL] [Abstract][Full Text] [Related]
9. Cyclic RGD-Decorated Liposomal Gossypol AT-101 Targeting for Enhanced Antitumor Effect.
Liu H; Zhang R; Zhang D; Zhang C; Zhang Z; Fu X; Luo Y; Chen S; Wu A; Zeng W; Qu K; Zhang H; Wang S; Shi H
Int J Nanomedicine; 2022; 17():227-244. PubMed ID: 35068931
[TBL] [Abstract][Full Text] [Related]
10. Enhanced anticancer efficacy of paclitaxel through multistage tumor-targeting liposomes modified with RGD and KLA peptides.
Sun J; Jiang L; Lin Y; Gerhard EM; Jiang X; Li L; Yang J; Gu Z
Int J Nanomedicine; 2017; 12():1517-1537. PubMed ID: 28280323
[TBL] [Abstract][Full Text] [Related]
11. A pH-responsive cell-penetrating peptide-modified liposomes with active recognizing of integrin αvβ3 for the treatment of melanoma.
Shi K; Li J; Cao Z; Yang P; Qiu Y; Yang B; Wang Y; Long Y; Liu Y; Zhang Q; Qian J; Zhang Z; Gao H; He Q
J Control Release; 2015 Nov; 217():138-50. PubMed ID: 26368312
[TBL] [Abstract][Full Text] [Related]
12. A dual-targeting liposome conjugated with transferrin and arginine-glycine-aspartic acid peptide for glioma-targeting therapy.
Qin L; Wang CZ; Fan HJ; Zhang CJ; Zhang HW; Lv MH; Cui SD
Oncol Lett; 2014 Nov; 8(5):2000-2006. PubMed ID: 25289086
[TBL] [Abstract][Full Text] [Related]
13. Tumor-targeted paclitaxel delivery and enhanced penetration using TAT-decorated liposomes comprising redox-responsive poly(ethylene glycol).
Fu H; Shi K; Hu G; Yang Y; Kuang Q; Lu L; Zhang L; Chen W; Dong M; Chen Y; He Q
J Pharm Sci; 2015 Mar; 104(3):1160-73. PubMed ID: 25449709
[TBL] [Abstract][Full Text] [Related]
14. Dual Receptor Targeting Cell Penetrating Peptide Modified Liposome for Glioma and Breast Cancer Postoperative Recurrence Therapy.
Qiu Y; Yu Q; Liu Y; Tang J; Wang X; Lu Z; Xu Z; He Q
Pharm Res; 2018 Apr; 35(7):130. PubMed ID: 29700620
[TBL] [Abstract][Full Text] [Related]
15. Targeted delivery of transferrin and TAT co-modified liposomes encapsulating both paclitaxel and doxorubicin for melanoma.
Yuan M; Qiu Y; Zhang L; Gao H; He Q
Drug Deliv; 2016 May; 23(4):1171-83. PubMed ID: 26036724
[TBL] [Abstract][Full Text] [Related]
16. Increased tumor targeted delivery using a multistage liposome system functionalized with RGD, TAT and cleavable PEG.
Mei L; Fu L; Shi K; Zhang Q; Liu Y; Tang J; Gao H; Zhang Z; He Q
Int J Pharm; 2014 Jul; 468(1-2):26-38. PubMed ID: 24709209
[TBL] [Abstract][Full Text] [Related]
17. Liposomes actively recognizing the glucose transporter GLUT
Fu Q; Zhao Y; Yang Z; Yue Q; Xiao W; Chen Y; Yang Y; Guo L; Wu Y
Arch Pharm (Weinheim); 2019 Feb; 352(2):e1800219. PubMed ID: 30609116
[TBL] [Abstract][Full Text] [Related]
18. RGD conjugated liposome-hollow silica hybrid nanovehicles for targeted and controlled delivery of arsenic trioxide against hepatic carcinoma.
Fei W; Zhang Y; Han S; Tao J; Zheng H; Wei Y; Zhu J; Li F; Wang X
Int J Pharm; 2017 Mar; 519(1-2):250-262. PubMed ID: 28109899
[TBL] [Abstract][Full Text] [Related]
19. [Physicochemical Property of iRGD Peptide Modified Doxorubicin Loaded Liposome and Its Effect on Cancer Cell Growth].
Zhang ZQ; Zhong CL; Zhao X
Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Nov; 46(6):837-41. PubMed ID: 26867317
[TBL] [Abstract][Full Text] [Related]
20. Improved tumor-targeting drug delivery and therapeutic efficacy by cationic liposome modified with truncated bFGF peptide.
Chen X; Wang X; Wang Y; Yang L; Hu J; Xiao W; Fu A; Cai L; Li X; Ye X; Liu Y; Wu W; Shao X; Mao Y; Wei Y; Chen L
J Control Release; 2010 Jul; 145(1):17-25. PubMed ID: 20307599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
